• Entity registrant name: Evogene Ltd. (CIK: 0001574565)
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1574565/000117891318001042/0001178913-18-001042-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1574565/000117891318001042/evgn-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • XBRL Cloud Rendering (requires license): Click to open XBRL Cloud Component Rendering
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001574565
  • Open this page in separate window: Click

    • * * *

    Component: (Network and Table)
    Network
    00000002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
    (http://evogene.com/role/ConsolidatedStatementsOfFinancialPosition)
    Table (Implied)
    Slicers (applies to each fact value in each table cell)
    Reporting Entity [Axis] 0001574565 (http://www.sec.gov/CIK)
    Statement of financial position [abstract] Period [Axis]
    2017-12-31
    2016-12-31
    Statement of financial position [abstract]
     
     
    CURRENT ASSETS:
     
     
    Cash and cash equivalents
    3,435,000  
    3,236,000  
    Restricted cash
    47,000  
    47,000  
    Marketable securities
    59,940,000  
    71,738,000  
    Short-term bank deposits
    8,380,000  
    13,137,000  
    Trade receivables
    132,000  
    169,000  
    Other receivables
    857,000  
    1,163,000  
    Total current assets
    72,791,000  
     
    89,490,000  
     
    LONG-TERM ASSETS:
     
     
    Long-term deposits
    19,000  
    13,000  
    Property, plant and equipment, net
    4,792,000  
    6,483,000  
    Total long term assets
    4,811,000  
     
    6,496,000  
     
    Total assets
    77,602,000  
     
    95,986,000  
     
    CURRENT LIABILITIES:
     
     
    Trade payables
    1,110,000  
    1,330,000  
    Other payables
    2,934,000  
    2,803,000  
    Liabilities in respect of government grants
    104,000  
    125,000  
    Deferred revenues and other advances
    516,000  
    967,000  
    Total current liabilities
    4,664,000  
     
    5,225,000  
     
    LONG-TERM LIABILITIES:
     
     
    Liabilities in respect of government grants
    3,438,000  
    3,303,000  
    Deferred revenues and other advances
    89,000  
    138,000  
    Severance pay liability, net
    33,000  
    31,000  
    Total non-current liabilities
    3,560,000  
     
    3,472,000  
     
    SHAREHOLDERS' EQUITY:
     
     
    Ordinary shares of NIS 0.02 par value: Authorized - 150,000,000 ordinary shares; Issued and outstanding - 25,750,547 and 25,480,809 shares at December 31, 2017 and 2016, respectively
    142,000  
    141,000  
    Share premium and other capital reserve
    186,268,000  
    183,342,000  
    Accumulated deficit
    (117,032,000) 
    (96,194,000) 
    Shareholder's Equity
    69,378,000  
     
    87,289,000  
     
    Shareholder's Equity and Liabilities
    77,602,000  
     
    95,986,000